STE — STERIS plc Stock Price, Chart & AI Report

Positive Jan 28, 2026 • 21:30 UTC Benzinga • Globe Newswire

STERIS Announces Dividend of $0.63 per share

STERIS plc announced a quarterly dividend of $0.63 per share, payable on March 19, 2026, to shareholders of record as of February 17, 2026. The company, a leading global provider of infection prevention products and services for healthcare and life sciences, continues its dividend distribution program.

STE dividend announcement quarterly dividend shareholder returns infection prevention healthcare products

Sentiment note

The announcement of a quarterly dividend demonstrates the company's financial health and confidence in its cash flow generation. Dividend payments are generally viewed positively by investors as they represent a return of capital and indicate management's confidence in the company's ability to sustain and grow earnings.

Neutral Dec 23, 2025 • 13:00 UTC GlobeNewswire Inc. • Coopercompanies

CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

CooperCompanies announced the appointment of Walt M Rosebrough, Jr., former CEO of STERIS, as an independent director effective January 3, 2026, following a cooperation agreement with activist investor Browning West. Rosebrough will join the Corporate Governance & Nominating Committee with consideration for Board Chair by end of 2026. The company also committed to appointing a new independent director with medical technology experience.

COO STE board appointment activist investor corporate governance medical device board chair cooperation agreement

Sentiment note

STERIS is mentioned only as context regarding Rosebrough's previous role and accomplishments. The article does not contain information about STERIS's current operations or outlook, warranting a neutral sentiment.

Neutral Oct 29, 2025 • 20:30 UTC Benzinga • Globe Newswire

STERIS Announces Dividend of $0.63 per share

STERIS plc announced a quarterly dividend of $0.63 per share, payable on December 18, 2025, to shareholders of record as of November 18, 2025. The company is a global provider of healthcare and life science products focused on infection prevention.

STE dividend healthcare infection prevention quarterly distribution

Sentiment note

The announcement is a standard corporate dividend declaration with no significant positive or negative implications. The company provides routine financial information about its dividend distribution.

Positive Aug 15, 2025 • 16:51 UTC GlobeNewswire Inc. • Globe Newswire

Dominican Republic Celebrates Free Zone Day Showcasing Global Industry Leaders

The Dominican Republic celebrated National Free Zones Day, highlighting its strategic potential for global manufacturing and innovation. Key executives from international companies shared success stories, emphasizing the country's skilled workforce, strategic location, and business-friendly environment.

STE free zones manufacturing semiconductors investment economic growth

Sentiment note

Chose Dominican Republic to strengthen medical devices supply chain after careful analysis

Positive Jul 30, 2025 • 20:30 UTC Benzinga • Globe Newswire

STERIS Raises Dividend to $0.63 per share

STERIS plc announced a quarterly dividend increase of $0.06 to $0.63 per share, marking its 20th consecutive year of dividend growth. The dividend will be payable on September 26, 2025, to shareholders of record as of September 4, 2025.

STE dividend quarterly healthcare infection prevention

Sentiment note

Company demonstrated consistent dividend growth for 20 consecutive years and increased dividend amount, indicating financial stability and shareholder confidence

Positive Jul 17, 2025 • 13:00 UTC GlobeNewswire Inc. • Marketsandmarkets

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™

The global single-use surgical instruments market is projected to grow from $5.92 billion in 2025 to $7.80 billion by 2030, driven by demands for sterility, efficiency, and reduced infection risks in surgical procedures.

MDT BDX SNN STE surgical instruments medical technology healthcare innovation single-use tools

Sentiment note

Highlighted for strategic acquisition of BD's instrumentation business

Neutral Jul 9, 2025 • 17:00 UTC GlobeNewswire Inc. • Delveinsight

Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight

The global medical device cleaning market is projected to grow at a CAGR of ~7% by 2032, driven by increasing surgical procedures, infection control awareness, and stricter regulatory guidelines for medical device sterilization.

GNGBY STE ECL medical device cleaning sterilization infection control healthcare surgical instruments

Sentiment note

Mentioned as a key market player without specific performance details

Positive May 28, 2025 • 08:58 UTC GlobeNewswire Inc. • Researchandmarkets.Com

Sterilization Monitoring Market Surges Towards USD 1.31 Billion by 2030 Amid Rising Demand for Real-Time Validation

The sterilization monitoring market is expected to grow at a CAGR of 6.77% from 2025 to 2030, driven by technological advancements, regulatory demands, and sustainability considerations. Key trends include automation, digital integration, and the adoption of alternative sterilization methods.

MMM STE TMO GNGBY sterilization monitoring automation digital integration alternative sterilization methods

Sentiment note

STERIS plc is also listed as one of the key players in the sterilization monitoring market, suggesting its prominence and ability to capitalize on the market's expansion.

Positive Mar 4, 2025 • 18:00 UTC GlobeNewswire Inc. • Delveinsight

Global Operating Room Equipment Market is Predicted to Cross ~USD 40 Billion by 2032 | DelveInsight

The operating room equipment market is experiencing strong growth, driven by the increasing volume of surgical procedures and the growing incidence of chronic diseases, particularly among the aging population. North America is expected to dominate the market, with technological advancements and investments in research and development by key players fueling the demand for cutting-edge operating room equipment.

PHG MDT SYK JNJ operating room equipment surgical procedures chronic diseases aging population

Sentiment note

STERIS plc is mentioned as a key player in the operating room equipment market, indicating their significant role and potential in the industry.

Positive Feb 3, 2025 • 17:00 UTC GlobeNewswire Inc. • Future Market Insights, Inc.

Surgical Booms Market 2025 to 2035 Projected Growth USD 477.7 Million at a 4.3% of CAGR | Future Market Insights, Inc.

The global surgical booms market is expected to grow from $317.1 million in 2025 to $477.7 million by 2035, driven by the increasing adoption of minimally invasive surgeries and advancements in operating room technology.

SYK STE GNGBY surgical booms operating rooms minimally invasive surgeries healthcare technology

Sentiment note

The article highlights the growing emphasis on infection control in healthcare settings, which could benefit Steris Plc as a provider of infection prevention and other healthcare solutions.

Positive Jan 21, 2025 • 10:00 UTC GlobeNewswire Inc. • Straits Research

Antiseptics and Disinfectants Market Size to Worth USD 100.89 billion by 2033, at a CAGR of 9.5% | Straits Research

The global antiseptics and disinfectants market is expected to grow from $48.81 billion in 2025 to $100.89 billion by 2033, driven by the increasing prevalence of hospital-acquired infections and the growing use of endoscope reprocessors and surgical units.

MMM RBGLY STE KMB antiseptics disinfectants hospital-acquired infections endoscope reprocessors

Sentiment note

The article lists STERIS plc as one of the key players in the antiseptics and disinfectants market, suggesting the company's strong presence and potential to benefit from the market's growth.

Positive Jan 17, 2025 • 15:00 UTC GlobeNewswire Inc. • Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.)

Endoscope Reprocessing Device Market Set to Reach USD 4.94 Billion by 2035 At A 7.3% of CAGR, driven by Rising Demand for Infection Control and Cardiovascular Diagnostics | FMI

The global endoscope reprocessing device market is projected to reach USD 4.94 billion by 2035, growing at a CAGR of 7.3%. This growth is driven by increased awareness of healthcare-associated infections and the need for enhanced infection prevention practices, as well as technological advancements in automated reprocessing devices.

GNGBY STE endoscope reprocessing infection control cardiovascular diagnostics automated reprocessing devices

Sentiment note

STERIS plc is listed as one of the key players in the endoscope reprocessing device market, implying its significant role and potential to contribute to the market's growth.